Searched for
GLP 1RA
Dr Reddy's launches oral semaglutide biosimilar Obeda in IndiaDr. Reddy's Laboratories proudly presents Obeda, a groundbreaking oral semaglutide biosimilar for managing Type 2 diabetes in India. This i...- Delhi HC seeks regulator's reply after PIL questions Ozempic, Mounjaro nodThe Delhi High Court has instructed India's drug regulator to address concerns about the approval process for drugs like Ozempic and Mounja...
- Not Ozempic, but this helped Lizzo shed body fat! Read all about her drastic transformationLizzo recently shared details about her weight-loss journey, saying she leaned on a calorie deficit diet in order to lose as much as 16 per...
- New study on Ozempic reveals shocking effects on eating habitsA new study into GLP-1RA drugs provides previously unknown insights into the impact this class of drugs may have on eating habits. The stud...
- Weight-loss drugs: Study involving 2 million people identifies potential benefits beyond obesity treatment and other risksThe study in Nature Medicine explores the potential wider benefits and risks of diabetes drugs GLP-1 receptor agonists. Besides weight loss...
- At over 10 cr, India’s diabetic population is surging, yet the country lags behind in prescribing new medicinesPriya Rao experienced confusion and worry after fainting and receiving different diabetic medications from two doctors. The first doctor fo...
Load More